[1] SUN X, VILAR S, TATONETTI N P. High-throughput methods for combinatorial drug discovery[J]. Science translational medicine, 2013, 5(205):205rv1. [2] 陈畅, 马兴, 满国峰,等. 组合药物——现代药物研发的新趋势[J]. 中国实验方剂学杂志, 2012, 18(14):310-312. [3] SUCHER N J. Searching for synergy in silico, in vitro and in vivo[J]. Synergy, 2014, 1(1):30-43. [4] ZOU J, JI P, ZHAO Y L, et al. Neighbor communities in drug combination networks characterize synergistic effect[J]. Molecular biosystems, 2012, 8(12):3185-3196. [5] ALAIMO S, BONNICI V, CANCEMI D, et al. DT-Web:a Web-based application for drug-target interaction and drug combination prediction through domain-tuned network-based inference[J]. BMC system biology, 2015,9(S3):S4-S4. [6] PANG K, WAN Y W, CHOI W T, et al. Combinatorial therapy discovery using mixed integer linear programming[J]. Bioinformatics, 2014,30(10):1456-1463. [7] 吕琳媛. 复杂网络链路预测[J]. 电子科技大学学报, 2010(5):651-661. [8] SID, REDNER. Networks:teasing out the missing links[J]. Nature, 2008, 453(7191):47-48. [9] YU H, BRAUN P, YILDIRIM M A, et.al. High-quality binary protein interaction map of the yeast interactome network[J]. Science, 2008, 322(5898):104-110. [10] 贾成龙. 基于网络模型和多源数据集成预测长非编码RNA-疾病关联关系[D]. 西安:西安电子科技大学, 2017. [11] 杨超,朱东华,衡晓帆,等. 基于语法树的SAO结构识别方法研究[J]. 图书情报工作, 2016,60(21):113-121. [12] 杨超, 朱东华, 汪雪锋,等. 专利技术主题分析:基于SAO结构的LDA主题模型方法[J]. 图书情报工作, 2017,61(3):86-96. [13] YOON J. Identifying technological competition trends for R&D planning using dynamic patent maps:SAO-based content analysis[J]. Scientometrics, 2013,94(1):313-331. [14] 翟东升, 蔡文浩, 张杰,等. 基于图相似度的专利侵权检测方法研究[J]. 图书情报工作, 2018,62(5):97-105. [15] 丁云轩, 闫雷. 数据挖掘软件SemRep的评价[J]. 中华医学图书情报杂志, 2008, 17(6):71-75. [16] XU R, LI L, WANG Q. dRiskKB:a large-scale disease-disease risk relationship knowledge base constructed from biomedical text[J]. BMC bioinformatics, 2014, 15:105. [17] XU K J, SONG J, ZHAO X M. The drug cocktail network[J]. BMC system biology, 2012, 6(S1):S5. [18] CHEN X, REN B, CHEN M, et al. NLLSS:predicting synergistic drug combinations based on semi-supervised learning[J]. PLoS computational biology, 2016, 12(7):e1004975. [19] JANSEN G, LEE A Y, EPP E, et al. Chemogenomic profiling predicts antifungal synergies[J]. Molecular systems biology, 2009, 5(1):338. [20] 刘彦斌. 组合药物数据库构建及药物协同作用机理分析[D]. 杭州:浙江大学, 2011. [21] RITAB A, ANJA T, JACOB B, et al. Species-specific activity of antibacterial drug combinations[J]. Nature, 2018, 559(7713):259-263. [22] HANLEY J A, MCNEIL B J. The meaning and use of the area under a receiver operating characteristic (ROC) curve[J]. Radiology, 1982, 143(1):29-36. [23] 蒋智华. 艾滋病合并隐孢子虫感染的研究进展[J]. 中国艾滋病性病, 2014, 20(12):955-958. [24] CRUZ P D, PRIDEAUX L, WAGNER J, et al. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease[J]. Inflammatory bowel diseases, 2012(2):372-390. [25] FESTEN E A M, GOYETTE P, GREEN T, et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for crohn's disease and celiac disease[J]. PLoS genetics, 2011, 7(1):e1001283. |